Nifty Pharma Today: Index Performance, Stocks, Gainers

Updated: 12 Aug 2026 • 4:07 pm

Posted by:

Nifty Pharma Today: Index Performance, Stocks, Gainers

Nifty Pharma today closed with a marginal gain, reflecting a session where broad participation stayed positive even though the headline move was small. The index stood at 26,762.5, up 12.05 points or 0.05% from the previous close of 26,750.45. That makes this a mildly positive day rather than a strong trending one, but the internal picture was healthier than the headline suggests because a clear majority of stocks in the index ended in the green.

For users tracking Nifty Pharma live, Nifty Pharma performance, and Nifty Pharma stocks today, the most important takeaway is that the sector held steady after opening near flat, slipping to an intraday low of 26,601.7, and then recovering toward the upper end of the day’s range. The index opened at 26,763.85, almost unchanged from the prior close, and later touched a day high of 26,797.9. That intraday structure points to resilience in buying interest after the early dip.

Within the constituent basket, advances were led by Zydus Lifesciences Ltd., Ipca Laboratories Ltd., and Ajanta Pharma Ltd.. On the downside, JB Chemicals & Pharmaceuticals Ltd. was the clear laggard, followed by Gland Pharma Ltd. and Alkem Laboratories Ltd.. Large and active names such as Sun Pharmaceutical Industries Ltd., Divi's Laboratories Ltd., Cipla Ltd., and Dr. Reddy's Laboratories Ltd. were relatively stable, which also helps explain why the overall index move remained contained.

This article gives a full, data-led view of Nifty Pharma today using verified index price action, market breadth, top gainers, top losers, heavyweight performance, and the complete available stock list. Where deeper metrics such as valuation multiples, fund flows, or indicator readings are not included here, the interpretation focuses on what today’s actual price and breadth data clearly show.

Table of Contents

Nifty Pharma Today Snapshot

Metric	Value
Current Value	26,762.5
Absolute Change	+12.05
Percentage Change	+0.05%
Opening Value	26,763.85
Previous Close	26,750.45
Today's High	26,797.9
Today's Low	26,601.7
Market Status	Closed
Last Updated	12 August 2026 at 4:00:00 PM IST
Market Trend	Sideways to mildly bullish

The Nifty Pharma index spent the day in a narrow net-change zone despite a wider intraday swing. Because the close was only slightly above the previous close, the headline performance may look quiet. However, the path of the day matters. The index fell meaningfully from near the opening level to the intraday low and then recovered back toward the day’s high zone before the close. That pattern generally indicates that sellers were active early but were not able to retain control through the session.

For short-term traders and investors searching “Nifty Pharma today” or “Nifty Pharma live,” this kind of session often signals consolidation rather than a decisive directional breakout. The sector did not show aggressive momentum, but it also did not break down despite weakness in a handful of names. The ability to recover after testing lower levels is one of the more constructive parts of today’s price action.

What Moved Nifty Pharma Today?

Based on the verified session data, today’s move in Nifty Pharma was driven mainly by stock-level dispersion rather than a broad one-way sector trend. The index itself ended only 0.05% higher, but 14 of 20 stocks advanced while only 5 declined and 1 ended unchanged. That tells us the sector’s internal breadth was positive, yet the gains were offset by sharper losses in select names.

The clearest drag came from JB Chemicals & Pharmaceuticals Ltd., which fell 3.87%, far steeper than any of the major gainers rose. When a single stock drops much more sharply than peers rise, it can mute the overall index result even if most constituents are positive. Additional softness in Gland Pharma Ltd. at -1.14% and Alkem Laboratories Ltd. at -0.86% also limited upside.

On the positive side, buying was visible across a wide range of names rather than being concentrated in only one stock. Zydus Lifesciences Ltd. rose 1.18%, Ipca Laboratories Ltd. gained 1.04%, and Ajanta Pharma Ltd. added 0.97%. Gains also extended to Natco Pharma Ltd., Glenmark Pharmaceuticals Ltd., Aurobindo Pharma Ltd., Abbott India Ltd., Mankind Pharma Ltd., and others. This broad spread of moderate advances is why the breadth remained strong.

Another important point is the behavior of heavyweight and active stocks. Sun Pharmaceutical Industries Ltd. gained 0.10%, Divi's Laboratories Ltd. rose 0.25%, and Torrent Pharmaceuticals Ltd. added 0.14%, while Cipla Ltd. was unchanged and Dr. Reddy's Laboratories Ltd. slipped 0.41%. When larger index names move only modestly, the overall index often stays subdued even if the stock-level advance-decline picture looks favorable.

So, the most accurate answer to “Why is Nifty Pharma moving today?” is this: the sector saw broad but mostly moderate buying across many constituents, while a few sharper losers prevented a stronger headline gain. The result was a nearly flat but internally constructive session.

Market Breadth: A Stronger Internal Picture Than the Headline

Breadth Metric	Value
Advancing Stocks	14
Declining Stocks	5
Unchanged Stocks	1
Advance-Decline Ratio	2.8
Stocks in Green	70%
Stocks in Red	25%

Market breadth is one of the best ways to judge the quality of a sector move. In Nifty Pharma today, breadth was clearly positive. Fourteen stocks advanced compared with only five decliners, while one stock ended unchanged. The advance-decline ratio of 2.8 means there were nearly three rising stocks for every one falling stock.

This matters because a positive breadth reading can reveal underlying strength even when the headline index return is small. A sector can rise sharply on narrow leadership, or it can move only slightly while many constituents participate. Today’s Nifty Pharma session falls into the second category. The gain of 0.05% may appear unremarkable, but the breadth suggests broader support under the surface.

At the same time, breadth should be interpreted carefully. A strong breadth figure does not automatically mean a powerful trend is underway. It simply tells us participation was favorable. Since some losing stocks fell more sharply than the winners rose, the breadth did not translate into a large index jump. Even so, from a market structure perspective, broad participation is usually healthier than dependence on one or two names alone.

Complete Nifty Pharma Constituent Performance

Company	CMP	Today's %	Today's Change	Day Open	Day High	Day Low	Trend
JB Chemicals & Pharmaceuticals Ltd.	2,408.9	-3.87%	-97.1	2,506	2,525.5	2,380	Bearish
Zydus Lifesciences Ltd.	1,205	+1.18%	+14	1,190	1,205	1,151	Bullish
Gland Pharma Ltd.	2,891.2	-1.14%	-33.2	2,924	2,949.9	2,860	Bearish
Ipca Laboratories Ltd.	1,766.6	+1.04%	+18.2	1,758.5	1,784.4	1,744	Bullish
Ajanta Pharma Ltd.	3,541	+0.97%	+34	3,500	3,555	3,485	Bullish
Natco Pharma Ltd.	915.3	+0.92%	+8.3	907.95	922.15	906	Bullish
Alkem Laboratories Ltd.	5,480	-0.86%	-47.5	5,518	5,534.5	5,411.5	Bearish
Glenmark Pharmaceuticals Ltd.	2,290	+0.62%	+14	2,276	2,310	2,272.4	Bullish
Aurobindo Pharma Ltd.	1,667	+0.54%	+9	1,658	1,667	1,652.3	Bullish
Granules India Ltd.	864.8	+0.44%	+3.8	857.5	870	854.4	Bullish
Abbott India Ltd.	28,140	+0.43%	+120	28,020	28,250	27,755	Bullish
Laurus Labs Ltd.	1,850	-0.43%	-8	1,856.3	1,862.3	1,835	Bearish
Dr. Reddy's Laboratories Ltd.	1,200	-0.41%	-5	1,206.8	1,206.8	1,190	Bearish
Mankind Pharma Ltd.	2,433.1	+0.33%	+8.1	2,418	2,433.1	2,381.3	Bullish
Biocon Ltd.	427.4	+0.33%	+1.4	427.75	430.5	422.6	Bullish
Divi's Laboratories Ltd.	8,600	+0.25%	+21.5	8,630	8,674	8,471.5	Mildly bullish
Torrent Pharmaceuticals Ltd.	4,893	+0.14%	+7	4,864	4,893.5	4,824.5	Mildly bullish
Sun Pharmaceutical Industries Ltd.	1,944	+0.10%	+2	1,942	1,945.7	1,926.8	Flat to positive
Lupin Ltd.	2,281	+0.09%	+2.1	2,286.6	2,287.8	2,249.5	Flat to positive
Cipla Ltd.	1,463	0.00%	0	1,460	1,468.8	1,456.1	Sideways

The top performer in percentage terms was Zydus Lifesciences Ltd., while the worst performer was JB Chemicals & Pharmaceuticals Ltd.. The table also shows that many gainers posted sub-1% moves, which supports the interpretation of a broad but measured positive bias rather than an aggressive sector rally.

Top Gainers in Nifty Pharma Today

Company	Price Change	% Change	Session Read
Zydus Lifesciences Ltd.	+14	+1.18%	Strongest gainer in the basket
Ipca Laboratories Ltd.	+18.2	+1.04%	Solid upward participation
Ajanta Pharma Ltd.	+34	+0.97%	Near-1% gain helped breadth
Natco Pharma Ltd.	+8.3	+0.92%	Firm intraday strength
Glenmark Pharmaceuticals Ltd.	+14	+0.62%	Contributed to broad-based gains

These gainers did most of the visible lifting in the sector. The pattern among them is notable: no stock posted an outsized multi-percentage surge, but several names delivered decent positive returns together. That kind of distributed leadership usually supports breadth and helps stabilize the index even when heavyweight names remain subdued.

Zydus Lifesciences Ltd. led the pack and closed at the top of its intraday band, matching its day high. Ipca Laboratories Ltd. and Ajanta Pharma Ltd. also showed healthy intraday follow-through. This is useful for readers looking beyond index-level noise to identify which pharma stocks showed stronger session momentum.

Top Losers in Nifty Pharma Today

Company	Price Change	% Change	Session Read
JB Chemicals & Pharmaceuticals Ltd.	-97.1	-3.87%	Sharpest drag on the sector
Gland Pharma Ltd.	-33.2	-1.14%	Meaningful pressure versus peers
Alkem Laboratories Ltd.	-47.5	-0.86%	Moderate weakness
Laurus Labs Ltd.	-8	-0.43%	Soft close in a positive-breadth market
Dr. Reddy's Laboratories Ltd.	-5	-0.41%	Mild decline in a heavyweight name

The bearish side was concentrated rather than broad. That is another reason today’s breadth stayed favorable. Still, the magnitude of the fall in JB Chemicals & Pharmaceuticals Ltd. was large enough to offset a meaningful portion of the gains elsewhere. In a sector index, this type of imbalance can keep the benchmark flat even when the majority of stocks are rising.

For market participants, this is an important lesson in reading sector performance. Counting winners and losers alone is not enough. One sharp downside move can carry more influence than several smaller gains, especially when larger names are not moving much.

Heavyweights and Most Active Pharma Stocks

The heavyweight and active list provides another layer of context for Nifty Pharma today. Sun Pharmaceutical Industries Ltd., Divi's Laboratories Ltd., Torrent Pharmaceuticals Ltd., Cipla Ltd., and Dr. Reddy's Laboratories Ltd. all traded within relatively restrained daily changes.

That matters because large, widely tracked constituents often shape the final index outcome. Today, heavier names were not weak enough to break the sector, but they were also not strong enough to turn positive breadth into a stronger index rally. For example, Sun Pharmaceutical Industries Ltd. rose just 0.10%, Divi's Laboratories Ltd. gained 0.25%, and Cipla Ltd. was unchanged. Such moves are supportive but not transformative.

At the same time, stability in these stocks often reduces the risk of sharp index volatility. In a session where one mid-basket loser dropped materially, steadier trading in heavyweights likely helped Nifty Pharma recover from the day’s low and finish marginally positive.

Price Action Analysis and Session Trend

Using the available price data, Nifty Pharma’s intraday chart suggests a sideways-to-mildly bullish structure. The index opened at 26,763.85, almost in line with the previous close of 26,750.45, then fell to 26,601.7 during the session. That low placed the index roughly 160 points below the open. From there, buyers pushed the benchmark back higher, and it closed at 26,762.5, almost exactly around the opening region and near the upper end of the day’s range.

This type of action usually indicates two things. First, there was no strong follow-through selling after the early weakness. Second, dip-buying or value-based support emerged at lower levels. If the close had remained near the day’s low, the tone would have been more decisively bearish. Instead, the recovery improved the session’s technical character.

The range between the day high of 26,797.9 and day low of 26,601.7 was meaningful enough to show active intraday repositioning, but the small net change signals that neither buyers nor sellers delivered a decisive end-of-day victory. For now, the most evidence-based classification is consolidation with a mildly positive bias, supported by healthy breadth and a recovery from intraday weakness.

Historical Context From Available Performance Data

Period	Performance
Today	+0.05%
Previous Session Reference	Index closed at 26,750.45

From the verified dataset available here, the clearest historical comparison is between today’s close and the previous close. Nifty Pharma improved by 12.05 points over that base. While this change is small in percentage terms, it becomes more informative when paired with the breadth and intraday recovery data discussed above.

Rather than treating the day as simply “flat,” investors may find it more useful to interpret it as a session of internal resilience. A tiny gain after a weak intraday patch, combined with 70% of stocks in green, generally presents a better picture than a superficial glance at the closing percentage might imply.

What Investors Should Watch Next in Nifty Pharma

For the next session, the first thing to watch is whether the sector can build on today’s broad participation. If advancers continue to outnumber decliners and heavyweight stocks also begin to show stronger gains, the index may convert today’s mild strength into a clearer directional move.

The second thing to watch is whether the sharp underperformance in JB Chemicals & Pharmaceuticals Ltd. remains isolated or starts spilling over into sentiment across other pharma names. Today, that weakness stayed contained, which is a positive sign. If similar stock-specific pressure expands to more constituents, breadth could weaken quickly.

Third, keep an eye on the behavior of major names such as Sun Pharmaceutical Industries Ltd., Divi's Laboratories Ltd., Cipla Ltd., Dr. Reddy's Laboratories Ltd., and Torrent Pharmaceuticals Ltd.. Their direction often decides whether Nifty Pharma remains range-bound or develops stronger momentum.

Finally, for those tracking sector rotation within the broader market, today’s breadth suggests that pharma participation was constructive even if the headline index move was limited. That makes the next few sessions especially relevant. Follow-through breadth with improving large-cap participation would strengthen the short-term setup. Weak breadth after today’s recovery would suggest the sector is still stuck in consolidation.

Key Takeaways

Nifty Pharma closed at 26,762.5, up 12.05 points or 0.05%.
The index opened near flat, fell intraday, and recovered toward the day’s upper range.
Market breadth was strong: 14 advancers, 5 decliners, and 1 unchanged stock.
The advance-decline ratio stood at 2.8, with 70% of constituents in green.
Zydus Lifesciences Ltd. was the top gainer, while JB Chemicals & Pharmaceuticals Ltd. was the top loser.
Heavyweights were mostly stable, which kept the index move limited despite broad participation.
The day’s trend can be described as sideways to mildly bullish based on recovery and breadth.

Featured Snippet Answers

What is Nifty Pharma? Nifty Pharma is a sectoral stock market index that tracks listed pharmaceutical companies in the Indian market. It helps investors measure the daily performance, breadth, and trend of pharma stocks as a group.

Why is Nifty Pharma moving today? Nifty Pharma moved marginally higher today because most constituent stocks advanced, but sharper declines in a few names, especially JB Chemicals & Pharmaceuticals, offset a large part of those gains.

Which stock contributed the strongest positive move today? In percentage terms, Zydus Lifesciences Ltd. was the strongest performer today, rising 1.18%.

Which stock fell the most in Nifty Pharma today?JB Chemicals & Pharmaceuticals Ltd. fell the most in Nifty Pharma today, declining 3.87%.

How many Nifty Pharma stocks advanced today? Fourteen Nifty Pharma stocks advanced today, five declined, and one ended unchanged.

Google AI Overview Style Summary

Nifty Pharma today closed marginally higher at 26,762.5, up 0.05%, after recovering from an intraday low of 26,601.7. The sector’s internal breadth was positive, with 14 advancing stocks against 5 decliners, indicating broader support than the headline move suggests. Top gainers included Zydus Lifesciences Ltd., Ipca Laboratories Ltd., and Ajanta Pharma Ltd., while JB Chemicals & Pharmaceuticals Ltd. was the sharpest loser. Investors may watch whether positive breadth continues and whether heavyweight pharma stocks add stronger support in the next session.

Published on 12 August 2026 at 4:05 PM IST

Frequently Asked Questions

1. What is the Nifty Pharma index today?

Nifty Pharma closed at 26,762.5 today, up 12.05 points or 0.05% from the previous close.

2. Is Nifty Pharma up or down today?

Nifty Pharma ended slightly up today. The index gained 0.05%, which indicates a marginally positive session.

3. Why is Nifty Pharma rising today?

Nifty Pharma rose today mainly because 14 out of 20 constituent stocks advanced. Broad participation supported the index even though a few sharper losers limited the upside.

4. Why was the Nifty Pharma gain small despite many stocks rising?

The gain stayed small because some losing stocks, especially JB Chemicals & Pharmaceuticals, fell more sharply than most gainers rose. That offset a large part of the broader positive participation.

5. Which stock gained the most in Nifty Pharma today?

Zydus Lifesciences Ltd. was the top gainer today with a 1.18% rise.

6. Which stock fell the most in Nifty Pharma today?

JB Chemicals & Pharmaceuticals Ltd. fell the most today, declining 3.87%.

7. How many Nifty Pharma stocks were in the green today?

Fourteen stocks were in the green today, which means 70% of the index constituents ended higher.

8. What was the advance-decline ratio for Nifty Pharma today?

The advance-decline ratio was 2.8, meaning there were nearly three advancing stocks for every one declining stock.

9. What were the day high and day low of Nifty Pharma?

Nifty Pharma touched a day high of 26,797.9 and a day low of 26,601.7.

10. Which heavyweight pharma stocks were stable today?

Sun Pharmaceutical Industries Ltd., Divi's Laboratories Ltd., and Cipla Ltd. were relatively stable compared with sharper movers in the sector.

11. What trend does Nifty Pharma show today?

Based on available price and breadth data, Nifty Pharma showed a sideways to mildly bullish trend today because it recovered from intraday weakness and closed slightly positive.

12. What should investors watch next in Nifty Pharma?

Investors should watch whether positive breadth continues, whether heavyweight stocks start contributing more strongly, and whether today’s sharp weakness in a few names remains isolated.

Disclaimer

Investments in securities markets are subject to market risks. Read all related documents carefully before investing. This sector-index update is for informational and educational purposes only and is not personalized investment advice or a recommendation to buy, sell, or hold any security.